Speaking Valve vs Capping Trial for Tracheostomy Decannulation in Stroke Patients
Official title: Comparison of Speaking Valve Trial and Capping Trial in the Decannulation Process for Stroke Patients: A Randomized, Controlled, Multicenter Study
Run by Capital Medical University · NCT07435727 · Data updated 2026-11-12
We’re testing whether using a Passy-Muir Speaking Valve helps decide when to remove a tracheostomy tube in stroke patients, compared with traditional tracheostomy tube capping.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Capital Medical University Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | May 15, 2027 |
| Study ends | August 15, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07435727 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Stroke patients with tracheostomies who are clinically stable, off ventilators for at least 48 hours, and meet the specified physiological criteria.
✕Probably not a fit
Patients with unstable condition, ongoing infections requiring IV antibiotics, or significant airway abnormalities may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized study compares two methods used before decannulation in stroke survivors: the Passy-Muir Speaking Valve and the traditional cuff deflation/capping approach. It is outcomes-assessor-blinded with an exploratory crossover element to gather robust safety and efficacy data across diverse centers. Eligible participants are post-acute stroke patients with tracheostomies who are clinically stable and off ventilators for at least 48 hours. The trial aims to determine which method better supports timely and safe decannulation while minimizing complications. Results could inform standardized decannulation protocols in stroke rehabilitation settings.
Why it matters
Potential benefit: If successful, the trial could identify a preferred method that enables faster, safer decannulation and improved communication for stroke patients.
How similar studies have gone: Previous approaches have shown mixed results; this study adds rigorous comparative data for decannulation strategies in stroke.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Stroke (ischemic or hemorrhagic) with subsequent tracheostomy. Stable stage of stroke: clinically in the post-acute or sequelae stage, with stable vital signs, resolved cerebral edema, normalized intracranial pressure, no new neurological deficits. Clinically stable, defined as: ventilator-free for ≥48 hours prior to enrollment; stable vital signs (temperature \<38°C, heart rate 60-100 bpm, respiratory rate \<20/min, systolic blood pressure 90-160 mmHg); no active severe infection requiring IV antibiotics; no organ failure; partial pressure of Carbon Dioxide(PaCO₂) \<60 mmHg. Peak Cough Flow (PCF) ≥100 L/min. 24-hour subglottic secretion volume \<20 ml. Signed informed consent by patient or legal representative. Exclusion Criteria: Intolerance to cuff deflation: severe cough, dyspnea, SpO₂ \<93% (on supplemental oxygen), or respiratory rate \>20/min for \>5 minutes. Severe airway structural abnormalities: tracheal stenosis (\>50% lumen occlusion confirmed by Computed Tomography or bronchoscopy), tracheoesophageal fistula. Life expectancy \<2 weeks or planned transfer to a non-participating institution within 2 weeks. Severe uncontrolled neurological or systemic diseases (e.g., advanced cancer, severe heart failure).
Where it's running
-
Beijing Rehabilitation Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Qian Feng
- Email: fengqian0263@163.com
- Phone: 17207122873
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.